Cargando…

Is There a Future for Traditional Immunogens When We Have mRNA?

Detalles Bibliográficos
Autores principales:	Kyuregyan, Karen K., Jansons, Juris, Isaguliants, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145088/ https://www.ncbi.nlm.nih.gov/pubmed/37110427 http://dx.doi.org/10.3390/microorganisms11041004

Ejemplares similares

Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5′ Terminus of Hepatitis C Virus RNA
por: Sominskaya, Irina, et al.
Publicado: (2015)

Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV-Related Liver Cancer
por: Jansons, Juris, et al.
Publicado: (2021)

We thrive not when we’ve done it all, but when we still have more to do (S. Lewis)
por: Hefti, F, et al.
Publicado: (2022)

Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model
por: Trofimova, Olga, et al.
Publicado: (2021)

HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells
por: Petkov, Stefan, et al.
Publicado: (2022)

Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?
por: Isaguliants, Maria, et al.
Publicado: (2022)

The Immunogenicity in Mice of HCV Core Delivered as DNA Is Modulated by Its Capacity to Induce Oxidative Stress and Oxidative Stress Response
por: Jansons, Juris, et al.
Publicado: (2019)

Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections
por: Parums, Dinah V.
Publicado: (2021)

The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
por: Malek, Alexandre E, et al.
Publicado: (2021)

Oh, the Lessons We Have Learned!
por: Zimmerman, Karen G., et al.
Publicado: (2017)

What have we learnt from Covid-19 Pandemia? Looking to the future
por: de Granda-Orive, J.I., et al.
Publicado: (2023)

mRNA Innovates the Vaccine Field
por: Pardi, Norbert
Publicado: (2021)

Recent Updates on mRNA Vaccines
por: Sydow, Emily, et al.
Publicado: (2022)

mRNA Metabolism in Health and Disease
por: Romão, Luísa
Publicado: (2022)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)

Algorithm for optimized mRNA design improves stability and immunogenicity
por: Zhang, He, et al.
Publicado: (2023)

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
por: Lee, Jisun, et al.
Publicado: (2023)

A 4D view on mRNA
por: Smith, Carlas, et al.
Publicado: (2015)

Cardiovascular disease, inflammation, and mRNA stability
por: Herman, Allison B., et al.
Publicado: (2018)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
Publicado: (2021)

Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients
por: Tsoutsoura, Paraskevi, et al.
Publicado: (2023)

Deciphering the Immunogenicity of Monkeypox Proteins for Designing the Potential mRNA Vaccine
por: Shah, Mohibullah, et al.
Publicado: (2023)

We have a problem!
por: Jankharia, Bhavin
Publicado: (2008)

mRNA Covid-19 Vaccines in Pregnant Women
por: Riley, Laura E.
Publicado: (2021)

1639. A Review of Clinical Safety, Reactogenicity, and Immunogenicity of an mRNA-Based Seasonal Influenza Vaccine (mRNA-1010) in Adults
por: Soens, Mieke, et al.
Publicado: (2023)

Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
por: Cagnazzo, Celeste, et al.
Publicado: (2020)

Steps We Have Taken and Steps We Must Take
por: Chang, Hyejung, et al.
Publicado: (2016)

Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients
por: Haller, Maria C., et al.
Publicado: (2022)

mRNA vaccines: Past, present, future
por: Karam, Mia, et al.
Publicado: (2022)

What do we mean when we say an operation works?
por: Villar, Richard
Publicado: (2016)

Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity
por: Uchida, Satoshi, et al.
Publicado: (2015)

COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing
por: Grau, Santiago, et al.
Publicado: (2022)

586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid Malignancies
por: Izaguirre, Natalie E, et al.
Publicado: (2021)

Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines
por: Alesci, Alessio, et al.
Publicado: (2022)

Safety and immunogenicity of mRNA COVID‐19 vaccine in inpatients with muscular dystrophy
por: Saito, Tomoko, et al.
Publicado: (2022)

Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
por: Lee, Yeji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_23sarof85thjj2ek51boq0i54s